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Introduction
The finding of solid contrast-enhancing renal masses on
imaging presents a diagnostic and therapeutic dilemma as
these are most likely to be malignant but can be benign.
We describe a patient with multiple solid renal masses
detected incidentally, who underwent open bilateral radical
nephrectomy for presumed renal cell carcinoma that proved
to be renal oncocytosis.
Case history
A 49-year-old woman underwent computed tomography
(CT) examination of the chest and abdomen following a road
traffic accident. This revealed bilateral solid renal masses. A
subsequent CT examination with intravenous contrast dem-
onstrated one solid enhancing lesion of 26 mm in the upper
pole of the right kidney and two solid enhancing lesions of
27 mm each in the left kidney, one of which extended into
the renal sinus fat (Figure 1). There was no evidence of
vascular invasion or lymphadenopathy. Since these lesions
were considered highly suspicious for renal cell carcinoma,
the patient was scheduled for an open bilateral partial neph-
rectomy. A biopsy was not performed because of concerns
about the potential for coexisting malignancy in patients
with benign change identified on biopsy.
The patient had Stage 4 chronic kidney disease as a result
of anti-neutrophil cytoplasmic antibody (cANCA)-positive
vasculitis treated 13 years previously but this was in remis-
sion on mycophenolate mofetil. Her creatinine concentra-
tion was 230 lmol/L (eGFR ¼ 20 mL/min) and she was
aware that she would ultimately require renal replacement
treatment. She was counselled about the possibility that
partial nephrectomy might be inappropriate and therefore
that bilateral nephrectomy might be necessary. She was
familiar with the treatment of end-stage renal disease
(ESRD) as her husband, father-in-law and sister-in-law
had all undergone renal transplantation for ESRD caused
by Adult Polycystic Kidney Disease.
On the day of surgery, the kidneys were exposed via a
midline incision. Multiple tumours were palpable throughout
both kidneys. These were much more extensive and numer-
ous than demonstrated by the CT examination, preclud-
ing nephron-sparing partial nephrectomy as previously
planned. Bilateral nephrectomy was therefore performed
after discussion in theatre with the renal physician res-
ponsible for her care. A Tenckhoff catheter was sited for
peritoneal dialysis.
Histopathology showed multiple oncocytic tumours
present within both kidneys, comprising nests, tubules and
solid sheets of cells with abundant eosinophilic cytoplasm
and round monomorphic nuclei showing minimal nuclear
atypia and no mitotic figures (Figure 2a). Immunohisto-
chemical staining (CK8/18 diffuse 1, CK7 focal single cell
cytoplasmic 1, c-kit diffuse 1, AMACR , Vimentin ,
RCC ) confirmed the tumours to be oncocytomas, with no
evidence of renal cell carcinoma. Renal parenchyma around
the tumours showed multiple microscopic foci of oncocyto-
sis (Figure 2b). In addition, the renal cortex showed moder-
ate chronic damage associated with focal segmental and
global glomerulosclerosis and marked glomerulomegaly, in-
dicative of hyperfiltration injury. There was no evidence of
active glomerulonephritis or vasculitis.
The patient made an uncomplicated recovery. After a
brief period of haemodialysis, she performed automated
peritoneal dialysis at home for 8 months before receiving
a living donor kidney transplant from her mother.
Discussion
The pathological diagnosis in this case was oncocytosis
with multiple oncocytomas. Renal oncocytomas are benign
tumours of the renal parenchyma, estimated to account for
3–9% solid renal masses [1, 2]. They are usually solitary
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lesions but several surgical case series have reported rates
of bilaterality or multifocality of 4–5% and 6–13%, res-
pectively [3, 4]. The coexistence of both bilateral and mul-
tifocal disease is rare and, as in this case, is sometimes
associated with renal oncocytosis, a condition where multi-
ple oncocytomas coexist with oncocytic change throughout
the kidney [5]. These oncocytic lesions can coexist with
chromophobe renal cell carcinoma. Although sometimes
associated with Birt-Hogg-Dube syndrome, the lack of skin
lesions or history of spontaneous pneumothorax make this
diagnosis unlikely in this patient. One recent case series
suggested that renal oncocytosis is a distinct entity from
isolated sporadic oncocytomas and chromophobe renal cell
carcinoma, with characteristic immunohistochemical and
genetic markers [6].
While this patient’s existing renal impairment is not
typical of patients with an incidentally detected renal
mass, her case does illustrate three key clinical dilemmas
in this field: (i) the difficulty of distinguishing benign from
malignant renal masses on imaging, (ii) the role of biopsy
in evaluation of renal masses and (iii) the potential for
conservative management of incidentally detected renal
masses.
The widespread use of imaging techniques such as CT
and magnetic resonance imaging has led to an increase
in the incidental detection of asymptomatic solid renal
masses, but the best management of such ‘incidentalomas’
is unclear.
As this case illustrates, it is frequently impossible to
distinguish benign from malignant lesions on imaging.
One retrospective case series of 143 solitary renal masses
diagnosed as renal cell carcinoma by experienced uroradi-
ologists found 16% of such lesions to be benign on histo-
pathological examination [7].
In particular, there is no method of reliably differentiat-
ing between renal cell carcinoma and oncocytoma with
current imaging techniques. Both appear as solid enhanc-
ing lesions on CT and features previously thought charac-
teristic of oncocytoma, such as a central stellate scar, have
been shown to be unreliable [8]. Some oncocytomas can
even show invasive features such as vascular or perinephric
invasion [4].
As a result, some patients undergo extensive surgery for
asymptomatic lesions which are then found to be benign.
A large study of 2935 solid renal masses resected between
1970 and 2000 at a single centre in the US found that 13%
were benign, of which 73% were oncocytomas [2]. The
proportion of benign lesions increased to 25% for masses
<3 cm in diameter.
The reported incidence of bilateral and multifocal dis-
ease appears to be similar for oncocytoma and renal cell
carcinoma, hence the detection of either characteristic on
preoperative imaging is unlikely to be of use in distinguish-
ing the two tumour types [9].
Given the uncertainty of pre-operative diagnosis, percu-
taneous needle core biopsy may be of use in the evalua-
tion of small renal masses. Until recently, renal core biopsy
was rarely performed due to concerns about low sensitivity,
immediate complications, such as haemorrhage and the
potential long-term risk of needle track seeding. However,
with recent improvements in technique and image guid-
ance, rates of minor complications are reported to be
Fig. 2. Histology of the nephrectomy specimens. (a) Part of an oncocy-
toma (haematoxylin and eosin staining,310 object magnification) and (b)
oncocytosis in renal cortex (haematoxylin and eosin staining, 320 object
magnification).
Fig. 1. Coronal CT with intravenous contrast.
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<5% with no cases of needle track seeding since 1994 [10].
The same review, which reviewed papers published since
2001, found the accuracy of renal mass biopsy (defined as
the percentage of biopsies with sufficient material for anal-
ysis in which the biopsy diagnosis was not indeterminate,
false negative or false positive) to be 88% compared to final
pathological diagnosis.
However, most such studies of percutaneous biopsy in
the investigation of small renal masses are retrospective
case series reviewing a highly selected population of pa-
tients who underwent biopsy rather than primary resection,
with only a proportion of biopsy diagnoses evaluated
against definitive histopathology on resected lesions.
Furthermore, oncocytomas present a particular challenge
in that certain renal cell carcinomas (such as the chromo-
phobe subtype) may be difficult to distinguish from onco-
cytoma on conventional histology, while in some cases,
oncocytic elements may coexist with renal cell carcinoma
[3]. A biopsy suggesting oncocytoma may therefore be
insufficient to rule out malignant disease, diminishing the
negative predictive value of biopsy and potentially result-
ing in greater diagnostic uncertainty. Markers such as
the S100A1 protein have been proposed as a method
for differentiating chromophobe renal cell carcinoma from
oncocytoma [11].
Use of percutaneous biopsy to obtain a pre-operative
histological diagnosis of incidentally detected small renal
masses has increased in recent years, as the value of
aggressive intervention in such patients has been chal-
lenged. Data from the US SEER cancer registry programme
suggest a rise in renal cancer mortality over the last few
decades despite increased detection of small tumours,
which challenges the prevailing assumption that the early
discovery of such lesions presents an opportunity for treat-
ment of less advanced disease and therefore better out-
comes [12]. Recent data demonstrating the adverse
effects of radical nephrectomy for small renal tumours on
long-term renal function have further underlined the need
to avoid radical resection [13]. Partial nephrectomy is now
the preferred option in tumours <4 cm. In the case of small
tumours or patients who are elderly or have significant
co-morbidity, monitoring may be all that is necessary,
thereby avoiding unnecessary surgical intervention. Other,
less invasive treatments for small renal lesions such as
radiofrequency ablation may be appropriate in certain
situations.
Although no randomized controlled trials of the manage-
ment of this problem have been carried out, a 2008 meta-
analysis of 286 ‘expectantly managed’ localized renal
masses reported a mean growth rate of 0.28 cm/year and
only three cases (1% of masses followed) of metastasis,
over a mean follow-up of 34 months [14]. This suggests
that watchful waiting, with regular clinical and radiological
review, is a justifiable management option to offer patients
with small renal masses, particularly those unfit or unwill-
ing to undergo surgery. However, it is important to note
that most of the available studies on expectant management
relate to patients who are older or who have multiple co-
morbidities, for whom long-term avoidance of cancer pro-
gression is less of an issue. Their value is also limited by the
relatively short duration of follow-up. Thus, the appropri-
ateness of expectant management of young and otherwise
healthy patients remains an open question because of un-
certainty about the risk of disease progression. The one
group for whom good evidence for this approach exists is
patients with Von Hippel-Lindau disease, 50% of whom
will develop renal cell carcinoma. In these patients, there
have been no reports of metastatic disease in the world
literature for any tumour <2.9 cm, so renal masses can
safely be observed until their tumour reaches 2.5 cm, at
which stage they should be removed [15].
In this case, the decision to proceed to bilateral nephrec-
tomy was made in the operating theatre by the surgeon and
the renal physician caring for the patient on the basis that
(i) malignancy in the failed kidneys could not be excluded
and (ii) end-stage renal disease was inevitable and its
advent likely to be accelerated by the multiple space occu-
pying lesions. Removal of the kidneys and establishing
the patient on dialysis allowed the possibility of cure and
then renal transplantation. She was told the results of the
histology after the surgery and that the tumours, although
space-occupying, were benign and agreed that the decision
was appropriate.
Although our patient’s existing chronic renal failure
meant that bilateral nephrectomy was an appropriate op-
tion, in patients with normal renal function, a more con-
servative approach to the incidentally detected renal mass
may often be justifiable.
Conclusions
The bilateral multifocal lesions in this case proved to be
oncocytosis with multiple oncocytomas. While this par-
ticular condition is rare, renal oncocytoma is a common
cause of a small renal mass and continues to present a
diagnostic dilemma for clinicians, given the limitations of
imaging in distinguishing benign and malignant lesions and
the potential morbidity associated with radical or partial
nephrectomy.
Teaching points
(1) Increasing use of abdominal imaging in recent decades
has led to more frequent detection of small renal
masses in asymptomatic patients. Management de-
pends on the size and position of the lesion as well
as the age and general health of the patient, necessitat-
ing careful discussion about the options and possible
outcomes.
(2) Imaging alone is insufficient for distinguishing benign
from malignant small renal masses in some situations,
resulting in some surgical resections being performed
for lesions ultimately found to be benign. Patients need
to be warned of the risk of this preoperatively, espe-
cially when small lesions are to be resected.
(3) Percutaneous renal biopsy may be safer and more in-
formative than previously thought but information on
this issue is limited.
(4) Many small renal masses grow slowly and have a low
risk of metastasis, so ‘watchful waiting’ may be an
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option in some patients, such as the elderly and those
with significant co-morbidity.
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